Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous

Chao Zhu1, Liqun Gu2, Zelong Liu3

  • 1Department of Stomatology, Xiangya Hospital, Central South University, Changsha, China.

BMC Cancer
|July 21, 2021
PubMed
Abstract

Insights

The VEGF signaling pathway correlates with immune cell infiltration and prognosis in head and neck squamous cell carcinoma (HNSCC). Combining anti-VEGF agents with immunotherapy may improve HNSCC treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Immunotherapy is vital in oncology but shows limited efficacy in head and neck squamous cell carcinoma (HNSCC).
  • The vascular endothelial growth factor (VEGF)/VEGF Receptor 2 (VEGFR2) pathway regulates tumor angiogenesis.
  • Combining immunotherapy with anti-angiogenic therapy is a potential strategy to enhance treatment effectiveness.

Purpose of the Study:

  • To investigate the correlation between the VEGF signaling pathway and the tumor immune microenvironment in HNSCC.
  • To explore the relationship between VEGF signaling and immune cell infiltration, gene expression, and patient prognosis.

Main Methods:

  • Utilized RNA sequencing and clinical data from The Cancer Genome Atlas (TCGA) database for HNSCC patients.
  • Analyzed immune cell infiltration, immune-related gene expression profiles, and immune-related biological pathways.
  • Performed functional enrichment analysis on differentially expressed genes.

Main Results:

  • The VEGF signaling pathway positively correlates with immune cell infiltration in HNSCC.
  • VEGF signaling is associated with immune-related gene expression profiles and improved patient prognosis.
  • Enrichment analysis revealed multiple immune-related biological processes linked to VEGF pathway activity.

Conclusions:

  • The VEGF signaling pathway is a significant factor in the HNSCC tumor immune microenvironment.
  • Combining anti-VEGF agents with immunotherapy, like immune checkpoint inhibitors (ICI), may offer therapeutic benefits for HNSCC patients.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K